is oprah on glp 1 Says GLP-1 Medications Led to Sobriety Oprah Winfrey shares what happened

If you couldn't resist that extra slice of pizza, it was labeled a "lack of willpower." But modern metabolic science is finally busting that myth

In this case, 5-h-fasted mice were intraperitoneally administered with 0.75 U of insulin (Sigma-Aldrich, MO, USA) per kg body weight, and blood glucose concentrations were determined before (0) and at 15, 30, 60, and 120 min after insulin injection

Vieira had been experiencing insulin resistance and stubborn weight gain, despite her active lifestyle

Qualifying comorbidities include type 2 diabetes, hypertension, dyslipidemia (abnormal cholesterol levels), and obstructive sleep apnea

Day 2: Balanced & Light Breakfast: Scrambled eggs (2) with spinach ( cup) and whole grain toast (1 slice) (350 kcal) Lunch: Lentil soup (1 cup) with whole grain crackers (4) and a side salad with olive oil dressing (450 kcal) Dinner: Turkey mince (120g) stir-fried with bell peppers and brown rice ( cup) (500 kcal) Snack: Greek yogurt (100g) with pumpkin seeds (1 tbsp) (200 kcal) Vegan Alternative: Swap turkey for stir-fried tempeh Day 3: Easy & Nutrient-Dense Breakfast: Protein smoothie with banana, protein powder, almond milk, and flaxseeds (350 kcal) Lunch: Chickpea salad (1 cup) with feta, cucumber, and olive oil dressing (450 kcal) Dinner: Grilled cod (120g) with roasted courgettes and quinoa ( cup) (500 kcal) Snack: 1 boiled egg and half an avocado (200 kcal) Vegan Alternative: Swap cod for grilled tofu or tempeh Day 4: Hydrating & Energy-Boosting Breakfast: Overnight oats ( cup) with almond milk, chia seeds, and mixed berries (350 kcal) Lunch: Grilled chicken (100g) with roasted butternut squash ( cup) and spinach (450 kcal) Dinner: Baked tofu (100g) with stir-fried broccoli, peppers, and brown rice ( cup) (500 kcal) Snack: Cottage cheese (100g) with a handful of walnuts (200 kcal) Hate cooking every day

How GLP-1 Receptor Agonists May Protect Against Cancer: The Mechanisms The cancer-preventive potential of GLP-1 therapy is understood to arise from several converging biological mechanisms, each addressing a distinct pathway through which metabolic dysfunction promotes oncogenesis